Effect of bone marrow-derived mesenchymal stem cells on cardiovascular complications in diabetic rats

Medical Science Monitor

Volumn 14, Issue 11, 2008, Pages

  Abdel Aziz, Mohamed Talaat ^a   El Asmar, Mohamed Farid ^b   Haidara, Mohamed ^a   Atta, Hazem Mahmoud ^a   Roshdy, Nagwa Kamal ^a   Rashed, Laila Ahmed ^a   Sabry, Dina ^a   Youssef, Mary Andraws ^a   Abdel Aziz, Ahmed Talaat ^a   Moustafa, Manal ^a  

^a CAIRO UNIVERSITY   (Egypt)

^b AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

Cardiovascular complications; Diabetes mellitus; Insulin; Mesenchymal stem cells

Indexed keywords

STREPTOZOCIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOVASCULAR DISEASE; CELL THERAPY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENETIC ANALYSIS; HEMATOPOIETIC STEM CELL; MALE; MESENCHYMAL STEM CELL; NONHUMAN; POLYMERASE CHAIN REACTION; RAT;

ANIMALS; ANTIGENS, CD29; BLOOD GLUCOSE; BLOOD PRESSURE; BODY WEIGHT; BONE MARROW CELLS; CARDIOVASCULAR DISEASES; CELL DIFFERENTIATION; CELLS, CULTURED; DIABETES COMPLICATIONS; FEMALE; INSULIN; MALE; MESENCHYMAL STEM CELLS; RATS;

EID: 55549083179     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Shapiro AM, Lakey JR, Ryan EA et al: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med, 2000; 343: 230-38
2. Benhamou PY, Oberholzer J, Toso C et al: Human islet transplantation network for the treatment of type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhône Alpes Geneve pour la transplantation d'Ilots de Langerhans. Diabetologia, 2001; 44: 859-64
3. Meier JJ, Bhushan A, Butlet PC: The Potential for Stem Cell Therapy in Diabetes Pediatr Res, 2006; 59 (4 Part 2): 65R-73
4. Soria B, Skoudy A, Martin F: From stem cells to beta cells: new strategies in cell therapy of diabetes mellitus. Diabetologia, 2001; 44: 407-15
5. Serup P, Madsen OD, Mandrup-Poulsen T: Islet and stem cell transplantation for treating diabetes. BMJ, 2001; 322: 29-32
6. Rosenberg L: In vivo cell transformation: neogenesis of beta cells from pancreatic ductal cells. Cell Transplant, 1995; 4: 371-83
7. Assady S, Maor G, Amit M et al: Insulin production by human embryonic stem cells. Diabetes, 2001; 50: 1691-97
8. Castaing M, Peault B, Basmaciogullari A et al: Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia, 2001; 44: 2066-76
9. Soria B, Roche E, Berna G et al: Insulin-secreting cells derived from embryonic stem cells normalize glycemia in streptozotocin-induced diabetic mice. Diabetes, 2000; 49: 157-62
10. Kojima H, Nakamura T, Fujita Y et al: Combined expression of pancreatic duodenal homeobox 1 and islet factor 1 induces immature enterocytes to produce insulin. Diabetes, 2002; 51: 1398-408
11. Yang L, Li S, Hatch H et al: In vitro transdifferentiation of adult hepatic stem cells into pancreatic endocrine hormone-producing cells. Proc Natl Acad Sci USA, 2002; 99: 8078-83
12. Ferber S, Halkin A, Cohen H et al: Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med, 2000; 6: 568-72
13. Bonner-Weir S, Taneja M, Weir GC et al: In vitro cultivation of human islets from expanded ductal tissue. Proc Natl Acad Sci USA, 2000; 97: 7999-8004
14. Ramiya VK, Maraist M, Arfors KE et al: Reversal of insulin-dependent diabetes using islets generated in vitro from pancreatic stem cells. Nat Med, 2000; 6: 278-82
15. Anderson DJ, Gage FH, Weissman IL: Can stem cells cross lineage boundaries? Nat Med, 2001; 7: 393-95
16. Pittenger MF, Mackay AM, Beck SC et al: Multilineage potential of adult human mesenchymal stem cells. Science, 1999; 284: 143-47
17. Lagasse E, Connors H, Al-Dhalimy M et al: Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med, 2000; 6: 1229-34
18. Krause DS, Theise ND, Collector MI et al: Multi-organ, multi-lineage engraftment by a single bone marrow-derived stem cell. Cell, 2001; 105: 369-77
19. Weissman IL: Stem cells: units of development, units of regeneration, and units in evolution. Cell, 2000; 100: 157-68
20. Deans RJ, Moseley AB: Mesenchymal stem cells: biology and potential clinical uses. Exp Hematol, 2000; 28: 875-84
21. Sanchez-Ramos J, Song S, Cardozo-Pelaez F et al: Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol, 2000; 164: 247-56
22. Woodbury D, Schwarz EJ, Prockop DJ, Black IB: Adult rat and human bone marrow stromal cells differentiate into neurons. J Neurosci Res, 2000; 61: 364-70
23. Alhadlaq A, Mao JJ: Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev, 2004; 13: 436-48
24. Rochefort GY, Vaudin P, Bonnet N et al: Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: possibilities of targeting pulmonary artery remodeling via cells therapies? Respir Res, 2005; 6: 125-27
25. Feng SW, Yao XL, Li Z et al: In vitro bromodeoxyuridine labeling of rat bone marrow-derived mesenchymal stem cells. Diyi Junyi Daxue Xuebao, 2005; 25: 184-86
26. Abdel Aziz MT, Atta HM et al: Therapeutic potential of bone marrow-derived mesenchymal stem cells on experimental liver fibrosis. Clinical Biochemistry, 2007; (in press)
27. Wang HS, Hung SC, Peng ST et al: Mesenchymal stem cells in the Wharton's jelly of the human umbilical cord. Stem Cells, 2004; 22: 1330-37
28. Thulesen J, Orskov C, Holst J, Poulsen SS: Short Term Insulin Treatment Prevents the Diabetogenic Action of Streptozotocin in Rats. Endocrinology, 1997; 138: 162-68
29. Chen LB, Jiang XB, Yang L: Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. Gastroenterology, 2004; 20: 3016-20
30. Wu GD, Tuan TL, Bowdish ME et al: Evidence for recipient derived fibroblast recruitment and activation during the development of chronic cardiac allograft rejection. Transplantation, 2003; 76: 609-14
31. An J, Beauchemin N, Albanese J et al: Use of a rat cDNA probe specific for the Y chromosome to detect male-derived cells. J Androl, 1997; 18: 289-93
32. Asahara T, Masuda H, Takahashi T et al: Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res, 1999; 85: 221-28
33. Tang DQ, Cao LZ, Burkhardt BR et al: In Vivo and In Vitro Characterization of Insulin-Producing Cells Obtained From Murine Bone Marrow. Diabetes, 2004; 53: 1721-32
34. Chen LB, Jiang XB, Yang L: Differentiation of rat marrow mesenchymal stem cells into pancreatic islet beta-cells. World J Gastroenterol, 2004; 10(20): 3016-20
35. Kojima H, Fujimiya M, Matsumura K et al: Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci USA, 2004; A101: 2458-63
36. Zalzman M, Gupta S, Giri RK et al: Reversal of hyperglycemia in mice by using human expandable insulin-producing cells differentiated from fetal liver progenitor cells. Proc Natl Acad Sci USA, 2003; A100: 7253-58
37. Holland S, Lebacqz K, Zoloth L: The human embryonic stem cell debate. Cambridge, MA, Massachusetts Institute of Technology, 2001
38. Hori Y, Rulifson IC, Tsai BC et al: Growth inhibitors promote differentiation of insulin-producing tissue from embryonic stem cells. Proc Natl Acad Sci USA, 2002; A99: 16105-10
39. Zulewski H, Abraham EJ, Gerlach MJ et al: Multipotential nestin-positive stem cells isolated from adult pancreatic islets differentiate ex vivo into pancreatic endocrine, exocrine, and hepatic phenotypes. Diabetes, 2001; 50: 521-33
40. Jiang Y, Jahagirdar BN, Reinhardt RL et al: Pluripotency of mesenchymal stem cells derived from adult marrow. Nature, 2002; 418: 41-49
41. Ianus A, Holz GG, Theise ND, Hussain MA: In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest, 2003; 111: 843-50.
42. Lechner A, Yang YG, Blacken RA et al: No Evidence for Significant Transdifferentiation of Bone Marrow Into Pancreatic β-Cells In Vivo. Diabetes, 2004; 53: 616-23
43. Hess D, Li L, Martin M et al: Bone marrow-derived stem cells initiate pancreatic regeneration. Nat Biotechnol, 2003; 21: 763-70
44. Terada N, Hamazaki T, Oka MY et al: Bone marrow cells adopt the phenotype of other cells by spontaneous cell fusion. Nature, 2002; 416: 542-45
45. Ying, QL, Nichols J, Evans EP, Smith AG: Changing potency by spontaneous fusion. Nature, 2002; 416: 545-48
46. Ianus A, Holz GG, Theise ND, Hussain MA: In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest, 2003; 111: 843-50
47. Fazan R Jr, Dias da Silva VJ, Ballejo G, Salgado HC: Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats. J Hypertens, 1999; 17: 489-95
48. Fazan R Jr, Ballejo G, Salgado MC et al: Heart rate variability and baroreceptor function in chronic diabetic rats. Hypertension, 1997; 30: 632-35
49. Schaan BD, Maeda CY, Timm HB et al: Time course of changes in heart rate and blood pressure variability in streptozotocin-induced diabetic rats treated with insulin. Braz J Med Biol Res, 1997; 30: 1081-86
50. Ramanadaham S, Tenner TE Jr: Chronic effects of streptozotocin diabetes on myocardial sensitivity in the rat. Diabetologia, 2006; 29: 741-48
51. Choi KM, Zhong Y, Hoit BD et al: Defective intracellular Ca(2+) signaling contributes to cardiomyopathy in Type 1 diabetic rats. Am J Physiol Heart Circ Physiol, 2002; 283: H1398-408
52. Zhang N, Li J, Luo R et al: Bone marrow mesenchymal stem cells induce angiogenesis and attenuate the remodeling of diabetic cardiomyopathy. Exp Clin Endocrinol Diabetes, 2008; 116(2): 104-11
53. Fazan R Jr, Dias da Silva VJ, Ballejo G, Salgado HC: Power spectra of arterial pressure and heart rate in streptozotocin-induced diabetes in rats. J Hypertens, 1999; 17: 489-95
54. Belke DD, Betuing S, Tuttle MJ et al: Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest, 2002; 109: 629-39
55. Fein FS, Strobeck JE, Malhotra A et al: Reversibility of diabetic cardiomyopathy with insulin in rats. Circ Res, 1981; 49: 1251-61
56. Villanueva DS, Poirier P, Standley PR, Broderick TL: Prevention of ischemic heart failure by exercise in spontaneously diabetic BB Wor rats subjected to insulin withdrawal. Metabolism, 2003; 52: 791-97
57. Stroedter D, Schmidt T, Bretzel RG, Federlin K: Glucose metabolism and left ventricular dysfunction are normalized by insulin and islet transplantation in mild diabetes in the rat. Acta Diabetol, 1995; 32: 235-43
58. Hink1 U, Li1 H, Mollnau H et al: Mechanisms Underlying Endothelial Dysfunction in Diabetes Mellitus. Circulation Research, 2001; 88: 14-22
59. Crespo MJ, Moreta S, Gonzalez J: Cardiovascular deterioration in STZ-diabetic rats: possible role of vascular RAS. Int J Exp C Pharma, 2003; 68: 1-8
60. De Angelis K, Schaan BD, Maeda CY et al: Cardiovascular control in experimental diabetes. Braz J Med Biol Res, 2002; 35: 1091-100
61. Canseco-Avila LM, Jerjes-Sánchez C, Ortiz-López R et al: Fibrinogen. Cardiovascular risk factor or marker? Arch Cardiol Mex. 2006; 76: 158-72